Pzena Investment Management LLC Sells 45,502 Shares of Henry Schein, Inc. $HSIC

Key Points

• Pzena Investment Management LLC reduced its stake in Henry Schein, Inc. by 4.7%, selling 45,502 shares, and now owns 0.76% of the company valued at approximately $67.2 million.
• Wall Street analysts have mixed opinions on Henry Schein, with five giving a Buy rating and eight a Hold rating, while the average target price is set at $76.67.
• Henry Schein's shares recently opened at $63.17 and reported $1.10 EPS for the last quarter, missing expectations by $0.09.

Pzena Investment Management LLC lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 4.7% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 920,231 shares of the company's stock after selling 45,502 shares during the period. Pzena Investment Management LLC owned 0.76% of Henry Schein worth $67,223,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Henry Schein by 3.5% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company's stock valued at $341,000 after acquiring an additional 157 shares during the last quarter. Clarius Group LLC bought a new position in shares of Henry Schein in the 2nd quarter valued at about $201,000. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Henry Schein by 4.1% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,526 shares of the company's stock valued at $1,134,000 after acquiring an additional 610 shares during the last quarter. Truist Financial Corp lifted its holdings in shares of Henry Schein by 21.1% in the 2nd quarter. Truist Financial Corp now owns 5,365 shares of the company's stock valued at $392,000 after acquiring an additional 934 shares during the last quarter. Finally, V Square Quantitative Management LLC lifted its holdings in shares of Henry Schein by 6.3% in the 2nd quarter. V Square Quantitative Management LLC now owns 3,377 shares of the company's stock valued at $247,000 after acquiring an additional 200 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Wall Street Analysts Forecast Growth

HSIC has been the subject of a number of analyst reports. Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Saturday. JPMorgan Chase & Co. reduced their price objective on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research report on Thursday, August 7th. Evercore ISI raised shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price objective on the stock in a research report on Tuesday, August 26th. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research report on Monday, July 14th. Finally, Robert W. Baird reissued a "neutral" rating and issued a $72.00 price objective (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Five research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $76.67.

Henry Schein Stock Down 2.2%

Shares of NASDAQ:HSIC opened at $63.17 on Monday. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The stock has a market cap of $7.66 billion, a P/E ratio of 20.38, a price-to-earnings-growth ratio of 2.08 and a beta of 0.81. The business's 50 day moving average is $67.48 and its 200 day moving average is $68.80. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same period last year, the company earned $1.23 EPS. The firm's revenue for the quarter was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Sell-side analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.